66 related articles for article (PubMed ID: 17707761)
21. Sorafenib and sunitinib in the treatment of advanced non-small cell lung cancer.
Gridelli C; Maione P; Del Gaizo F; Colantuoni G; Guerriero C; Ferrara C; Nicolella D; Comunale D; De Vita A; Rossi A
Oncologist; 2007 Feb; 12(2):191-200. PubMed ID: 17296815
[TBL] [Abstract][Full Text] [Related]
22. Sunitinib malate.
Izzedine H; Buhaescu I; Rixe O; Deray G
Cancer Chemother Pharmacol; 2007 Aug; 60(3):357-64. PubMed ID: 17136543
[TBL] [Abstract][Full Text] [Related]
23. Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy.
Tamaskar I; Garcia JA; Elson P; Wood L; Mekhail T; Dreicer R; Rini BI; Bukowski RM
J Urol; 2008 Jan; 179(1):81-6; discussion 86. PubMed ID: 17997441
[TBL] [Abstract][Full Text] [Related]
24. Hypothyroidism and Thyroid Autoimmunity as a Prognostic Biomarker of Better Response in Metastatic Cancer Long-Term Survivors Treated with Sunitinib.
Pani F; Atzori F; Baghino G; Boi F; Ionta MT; Tanca L; Scartozzi M; Mariotti S
Thyroid; 2016 Sep; 26(9):1336-7. PubMed ID: 27267354
[No Abstract] [Full Text] [Related]
25. Sunitinib (sutent)-induced thyrotoxicosis due to destructive thyroiditis: a case report.
Faris JE; Moore AF; Daniels GH
Thyroid; 2007 Nov; 17(11):1147-9. PubMed ID: 17714037
[TBL] [Abstract][Full Text] [Related]
26. Survival of a patient with anaplastic thyroid cancer following intensity-modulated radiotherapy and sunitinib--a case report.
Schoenfeld JD; Odejide OO; Wirth LJ; Chan AW
Anticancer Res; 2012 May; 32(5):1743-6. PubMed ID: 22593455
[TBL] [Abstract][Full Text] [Related]
27. Sunitinib-induced acute severe hypothyroidism in a case of metastatic gastrointestinal stromal tumor: A case report.
Manir KS; Banerjee D; Bhowmick R; Roy C
J Cancer Res Ther; 2018 Sep; 14(Supplement):S818-S819. PubMed ID: 30249914
[TBL] [Abstract][Full Text] [Related]
28. Sunitinib effective for rare thymus cancer.
Cancer Discov; 2015 Apr; 5(4):340. PubMed ID: 25680712
[TBL] [Abstract][Full Text] [Related]
29. Documentation of thyroid function in clinical studies with sunitinib: why does it matter?
Garfield DH; Wolter P; Schöffski P; Hercbergs A; Davis P
J Clin Oncol; 2008 Nov; 26(31):5131-2; author reply 5132-3. PubMed ID: 18824699
[No Abstract] [Full Text] [Related]
30. Tyrosine kinase inhibitor-induced hypothyroidism: incidence, etiology, and management.
Brown RL
Target Oncol; 2011 Dec; 6(4):217-26. PubMed ID: 22101606
[TBL] [Abstract][Full Text] [Related]
31. Sunitinib treatment reduces tumor growth and limits changes in microvascular properties after minor surgical intervention in an in vivo model of secondary breast cancer growth in bone.
Schroeder M; Viezens L; Wellbrock J; Fiedler W; Rüther W; Algenstaedt P; Hansen-Algenstaedt N; Schaefer C
J Surg Oncol; 2016 Apr; 113(5):515-21. PubMed ID: 26818116
[TBL] [Abstract][Full Text] [Related]
32. Sunitinib-induced severe hypothyroidism with cardiac compromise.
Collinson FJ; Vasudev NS; Berkin L; Khan MM; Selby PJ; Brown JE
Med Oncol; 2011 Dec; 28 Suppl 1():S699-701. PubMed ID: 21116874
[TBL] [Abstract][Full Text] [Related]
33. Refractory angiosarcoma of the breast with VEGFR2 upregulation successfully treated with sunitinib.
Silva E; Gatalica Z; Vranic S; Basu G; Reddy SK; Voss A
Breast J; 2015; 21(2):205-7. PubMed ID: 25639617
[No Abstract] [Full Text] [Related]
34. Alveolar soft part sarcoma in childhood: is Sunitinib-Sutent® treatment an effective approach?
Hilbert M; Mary P; Larroquet M; Serinet MO; Helfre S; Brisse H; Coulomb A; Orbach D
Pediatr Blood Cancer; 2012 Mar; 58(3):475-6. PubMed ID: 22234817
[No Abstract] [Full Text] [Related]
35. Skin ulcers in Klippel-Trenaunay syndrome respond to sunitinib.
Nguyen S; Franklin M; Dudek AZ
Transl Res; 2008 Apr; 151(4):194-6. PubMed ID: 18355766
[No Abstract] [Full Text] [Related]
36. Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?
Roviello G; Buti S; Cattrini C; Mennitto A; Messina C; Airoldi C; Vannini G; Bersanelli M
Ther Adv Urol; 2021; 13():17562872211029784. PubMed ID: 34290828
[No Abstract] [Full Text] [Related]
37. Treatment of hypothyroidism: possibilities on the horizon.
Jonklaas J; Burman KD; Bianco AC;
Thyroid; 2013 Apr; 23(4):ix-xi. PubMed ID: 23521210
[No Abstract] [Full Text] [Related]
38. The hypoglycemic side of hypothyroidism.
Kalra S; Unnikrishnan AG; Sahay R
Indian J Endocrinol Metab; 2014 Jan; 18(1):1-3. PubMed ID: 24701422
[No Abstract] [Full Text] [Related]
39. Partial remission of metastatic papillary thyroid carcinoma with sunitinib. Report of a case and review of the literature.
Kaldrymides P; Kostoglou-Athanassiou I; Gkountouvas A; Veniou E; Ziras N
Endocrine; 2010 Feb; 37(1):6-10. PubMed ID: 20963554
[TBL] [Abstract][Full Text] [Related]
40. [Sunitinib and hypothyroidism].
Cohen R; Bihan H; Uzzan B; des Guetz G; Krivitzky A
Ann Endocrinol (Paris); 2007 Oct; 68(5):332-6. PubMed ID: 17707761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
